Relay Therapeutics (RLAY)
(Delayed Data from NSDQ)
$6.58 USD
+0.17 (2.65%)
Updated Oct 10, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Earnings News For RLAY
-
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
-
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates
-
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
-
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
-
Relay Therapeutics, Inc. (RLAY) Expected to Beat Earnings Estimates: Should You Buy?
-
Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights
-
Relay Therapeutics, Inc. (RLAY) Expected to Beat Earnings Estimates: Should You Buy?
-
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Lags Revenue Estimates
-
Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights
-
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Misses Revenue Estimates
-
Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights
-
Relay Therapeutics, Inc. (RLAY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Misses Revenue Estimates
-
Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
-
Earnings Preview: Relay Therapeutics, Inc. (RLAY) Q4 Earnings Expected to Decline
-
Relay Therapeutics, Inc. (RLAY) Reports Q3 Loss, Lags Revenue Estimates
-
Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights